The Company has arranged Earnings Call with Investor/Analyst (Participants) to discuss the audited Standalone and Consolidated Financial Results of the Company for the quarter and financial ....
CONCORDBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Concord Biotech Limited has announced an earnings call for investors and analysts scheduled on Monday, June 01, 2026 at 2:30 PM IST to discuss the audited standalone and consolidated financial results for Q4FY26 and the full financial year ended March 31, 2026. The call is being hosted in partnership with Ambit Capital and will feature key company executives including Chairman and MD Mr. Sudhir Vaid, Joint MD and CEO Mr. Ankur Vaid, CFO Mr. Raviraj Karia, and Assistant VP – Accounts & Finance Mr. Prakash Sajnani. The meeting is held pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015. Dial-in details and international toll-free numbers are provided for participant access.
This is a standard regulatory disclosure notifying the market of an upcoming earnings call. It does not contain financial results or forward-looking statements. No immediate impact on the stock, but investors should note the June 1 date to participate in or await post-call updates.